Psychotropic Medications for Depression
02/22/24 • 34 min
Featured guest: Amy VandenBerg, PharmD, BCPP
Objectives
· Identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work.
· Identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.
· Discuss the black-box warning associated with these medications.
· Identify symptoms of serotonin syndrome.
· Identify symptoms of discontinuation syndrome.
Resources
· Selective serotonin reuptake inhibitors (StatPearls)
· Demystifying serotonin syndrome (or serotonin toxicity) (Canadian Family Physician)
· Antidepressant discontinuation syndrome (Canadian Medical Association Journal)
· Antidepressants and the FDA’s black-box warning: determining a rational public policy in the absence of sufficient evidence (AMA Journal of Ethics)
· Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison (Innovations in Clinical Neuroscience)
CME Credits available: 0.5
To enroll for CME credit, visit our episode activity website. Visit our CME course overview page for details on CME credit, or complete this survey for social work CEUs.
Visit our podcast website for more information about this episode and the Breaking Down Mental Health podcast series.
Breaking Down Mental Health is a part of the Michigan Medicine Podcast Network. You can subscribe to Breaking Down Mental Health podcast wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
Featured guest: Amy VandenBerg, PharmD, BCPP
Objectives
· Identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work.
· Identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.
· Discuss the black-box warning associated with these medications.
· Identify symptoms of serotonin syndrome.
· Identify symptoms of discontinuation syndrome.
Resources
· Selective serotonin reuptake inhibitors (StatPearls)
· Demystifying serotonin syndrome (or serotonin toxicity) (Canadian Family Physician)
· Antidepressant discontinuation syndrome (Canadian Medical Association Journal)
· Antidepressants and the FDA’s black-box warning: determining a rational public policy in the absence of sufficient evidence (AMA Journal of Ethics)
· Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison (Innovations in Clinical Neuroscience)
CME Credits available: 0.5
To enroll for CME credit, visit our episode activity website. Visit our CME course overview page for details on CME credit, or complete this survey for social work CEUs.
Visit our podcast website for more information about this episode and the Breaking Down Mental Health podcast series.
Breaking Down Mental Health is a part of the Michigan Medicine Podcast Network. You can subscribe to Breaking Down Mental Health podcast wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
Previous Episode
Child Protective Services
Featured guests: Breana Lewis, LMSW, and Martha Kerr, LMSW, Child Protection Team
Objectives:
- Define child protective services
- Identify who a mandated reporter is
- Complete a 3200
- Identify different ways in which child protective services can support a child and family
Resources:
Credits available: 0.75
Visit our website for more information about this episode and the Breaking Down Mental Health podcast series.
For CME credit details, including educational planning, financial relationship disclosures, and credit claiming instructions, visit https://ww2.highmarksce.com/micme/index.cfm?do=ev.viewEvent&style=1&eventID=73300.
To claim social work CEUs, visit https://umich.qualtrics.com/jfe/form/SV_73uW5rECA65wEVU
Breaking Down Mental Health is a part of the Michigan Medicine Podcast Network. You can subscribe to Breaking Down Mental Health podcast wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
Next Episode
Pediatric Depression
Featured guests: Joanna Quigley, M.D. and Alejandra Arango, Ph.D.
Objectives
· Review the neurobiology of depression.
· Determine appropriate screening tools for depression for the screening of children and adolescents.
· Differentiate between depression presentation in children versus adults.
Resources
· Mental Health Surveillance Among Children (CDC)
Disclosures
Alejandra Arango, Ph.D. has disclosed a relevant financial relationship with: Vita Health - Consultant/Advisory Role, Other - Teaching, Conflict is relevant but is managed. This relationship is relevant, this company does work in the topic area. but the relationship ended on 10/31/23.
CME Credits available: 0.5
To enroll for CME credit, visit our episode activity website. Visit our CME course overview page for details on CME credit, or complete this survey for social work CEUs.
Visit our podcast website for more information about this episode and the Breaking Down Mental Health podcast series.
Breaking Down Mental Health is a part of the Michigan Medicine Podcast Network. You can subscribe to Breaking Down Mental Health podcast wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/breaking-down-mental-health-450467/psychotropic-medications-for-depression-61389397"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to psychotropic medications for depression on goodpods" style="width: 225px" /> </a>
Copy